Brought to you by:
Bentley launches rebranded crossing catheter
Germany-based endovascular device company Bentley announced the launch of the BeBack crossing catheter—formerly known as the GoBack—designed for the treatment of heavily calcified lesions above and below the knee. Bentley acquired the catheter in September 2022 from Upstream Peripheral Technologies,…
Human-tissue engineered blood vessels remain durable at six years in PAD patients, latest study results show
Mid-term results from a phase II study of surgical bypass using the Human Acellular Vessel (HAV) demonstrated an overall secondary patency rate at 72 months of 60% measured by Kaplan Meier. There was no evidence of graft rejection or infection,…
JVS group: Further changes in store for 2023
The planned changes for 2023 for the Journal of Vascular Surgery publications continue the momentum that began in mid- 2022. As former Editor-in-Chief Peter Gloviczki, MD, and Senior Editor Peter Lawrence, MD, ended their six-year run as editors of all…
SVS unveils latest addition to JVS family of publications
The year 2023 promises to be one of change for the Journal of Vascular Surgery (JVS) family of publications, including the introduction of a fifth journal. JVS-Vascular Insights (JVS-VI) launched this month as an online-only, open-access (non-subscription) title. This model is…
SVS ends 2022 with latest ‘Week of Action’ to prevent Medicare payment reductions
The Society for Vascular Surgery (SVS) issued its thanks to December “Week of Action” participants. Once again, SVS members showed incredible support for the Society’s advocacy efforts by engaging in the week’s various activities and continuing to amplify the specialty’s…
SVS Foundation: ‘Gatsby’ Gala tickets on sale
Book your trip to the Roaring Twenties early, and save some money, perhaps for auction items. Early-bird ticket sales for the Society for Vascular Surgery (SVS) Foundation’s “Great Gatsby Gala,” to be held at the 2023 Vascular Annual Meeting (VAM), have…
SAVS 2023: President reveals upcoming change to Society seal
Southern Association for Vascular Surgery (SAVS) President William D. Jordan Jr., MD, used a portion of his 2023 Presidential Address to outline ways in which SAVS is set to further evolve as a professional body going forward. Titled “Anatomy and…
SVS Foundation changes name of program aimed at providing care for underserved patients
The Society for Vascular Surgery (SVS) Foundation program formerly known as VISTA has a new name. VISTA—an acronym for Vascular Volunteers In Service To All—is now simply Vascular Care for the Underserved™. Its mission, however, remains the same: “to provide…
The top 10 most popular Vascular Specialist stories of December 2022
Among the most-read Vascular Specialist stories in December 2022 were the promising results from a postmarket surveillance study of a paclitaxel DCB; the Society for Vascular Surgery (SVS) paid tribute to the passing of former president James (Jimmy) S.T. Yao,…
SAVS 2023: Study points toward CKD patients who would most benefit from renal artery stenting
A new study probing which chronic kidney disease (CKD) patients would benefit most from renal artery stenting points toward those who experience a more rapid decline in renal function over six months prior to the procedure. It is an area…